Dg. Armstrong et al., Lengthening of the Achilles tendon in diabetic patients who are at high risk for ulceration of the foot, J BONE-AM V, 81A(4), 1999, pp. 535-538
Citations number
34
Categorie Soggetti
Ortopedics, Rehabilitation & Sport Medicine","da verificare
Background The purpose of this study was to determine the degree to which p
ressure on the plantar aspect of the forefoot is reduced following percutan
eous lengthening of the Achilles tendon in diabetic patients who are at hig
h risk for ulceration of the foot.
Methods: Ten diabetic patients who had a history of neuropathic plantar ulc
eration of the forefoot were enrolled in a laboratory gait trial. A repeate
d-measures design and a computer analysis of force-plate data were used to
examine dynamic pressures on the forefoot,,vith the patient walking barefoo
t, immediately before percutaneous lengthening of the Achilles tendon and a
t eight weeks afterward. Although the wound in each patient had healed at l
east one month before the operation, we considered the patients to be at hi
gh risk for ulceration because they had had an ulcer previously.
Results: The mean peak pressure (and standard deviation) on the plantar asp
ect of the forefoot decreased significantly from 86 +/- 9.4 newtons per squ
are centimeter preoperatively to 63 +/- 13.2 newtons per square centimeter
at eight weeks postoperatively (p < 0.001), Commensurately, the mean dorsif
lexion of the ankle joint increased significantly from 0 +/- 3.1 degrees pr
eoperatively to 9 +/- 2.3 degrees at eight weeks postoperatively (p < 0.001
),
Conclusions: The results of this study suggest that peak pressures on the p
lantar aspect of the forefoot are significantly reduced following percutane
ous lengthening of the Achilles tendon in diabetic patients who are at high
risk for ulceration of the foot. We are unaware of any other reports in th
e medical literature that describe such findings. These data may lend suppo
rt to studies that have indicated that this procedure should be used as an
adjunctive therapeutic or prophylactic measure to reduce the risk of neurop
athic ulceration.